A detailed history of Alberta Investment Management Corp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Alberta Investment Management Corp holds 25,800 shares of HALO stock, worth $1.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,800
Previous 25,800 -0.0%
Holding current value
$1.23 Million
Previous $1.35 Million 9.33%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$37.81 - $52.4 $975,498 - $1.35 Million
25,800 New
25,800 $1.35 Million
Q2 2023

Aug 14, 2023

BUY
$30.28 - $38.74 $468,431 - $599,307
15,470 New
15,470 $558,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.